News
McSAF and Novasep announce their successful collaboration to produce a next-generation Antibody-Drug Conjugate
Novasep, a leading supplier of services and technologies for the life sciences industry, and McSAF, a French biotech based in Tours, specialized in bioconjugation...
Drug Research
Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline
Sanofi announced an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive...
News
New Zealand approves India-made vaccines, Covishield and Covaxin
New Zealand has finally approved India-made vaccines, Covishield and Covaxin. The decision comes soon after Australia, New Zealand’s neighbour, recognised the two Indian vaccines...
News
GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment
GlaxoSmithKline plc and Vir Biotechnology, Inc. announced US government contracts totalling approximately $1 billion (USD) to purchase sotrovimab, an investigational monoclonal antibody for the...
Industry Reports
MasterControl Announces Annual Recurring Revenue Milestone
MasterControl, a global provider of software solutions for life sciences and other regulated industries, announced it has reached $100 million in annual recurring revenue...
Press Releases
Pfizer and BioNTech Receive Expanded U.S. FDA EUA of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Pfizer Inc. and BioNTech SE announced that the U.S. FDA has expanded the EUA of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to...
Drug Research
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced it has launched...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read